spacer
home > ict > spring 2008 > solid supply
PAY PER VIEW SERVICE

 

Dear guest!

article: Solid Supply
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

Ubiquigent Appoints Dr Sheelagh Frame, CSO, to Its Board of Directors

Dundee, UK, 24 October 2022: Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitylase (DUB) modulators as powerful new therapeutics, today announced the appointment of Dr Sheelagh Frame, Chief Scientific Officer (CSO), to the Company’s Board of Directors. The appointment comes at a key stage in the Company’s development with the growing importance of the DUBs in drug discovery and will help drive the progress of Ubiquigent’s internal portfolio of novel DUB modulators, associated drug discovery programmes and commercial services.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement